Literature DB >> 16983326

New insights into the molecular control of the lymphatic vascular system and its role in disease.

Leah N Cueni1, Michael Detmar.   

Abstract

The cutaneous lymphatic system plays an important role in the maintenance of tissue fluid homeostasis, in the afferent phase of the immune response, and in the metastatic spread of skin cancers. However, the lymphatic system has not received as much scientific attention as the blood vascular system, largely due to a lack of lymphatic-specific markers and to the dearth of knowledge about the molecular regulation of its development and function. The recent identification of genes that specifically control lymphatic development and the growth of lymphatic vessels (lymphangiogenesis), together with the discovery of new lymphatic endothelium-specific markers, have now provided new insights into the molecular mechanisms that control lymphatic growth and function. Moreover, studies of several genetic mouse models have set the framework for a new molecular model for embryonic lymphatic vascular development, and have identified molecular pathways whose mutational inactivation leads to human diseases associated with lymphedema. These scientific advances have also provided surprising evidence that malignant tumors can directly promote lymphangiogenesis and lymphatic metastasis, and that lymphatic vessels play a major role in cutaneous inflammation and in the cutaneous response to UVB irradiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983326     DOI: 10.1038/sj.jid.5700464

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  68 in total

1.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

2.  Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.

Authors:  Fei Zhou; Zai Chang; Luqing Zhang; Young-Kwon Hong; Bin Shen; Bo Wang; Fan Zhang; Guangming Lu; Denis Tvorogov; Kari Alitalo; Brian A Hemmings; Zhongzhou Yang; Yulong He
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Reduction of lymphatic vessels in photodamaged human skin.

Authors:  Kentaro Kajiya; Rainer Kunstfeld; Michael Detmar; Jin Ho Chung
Journal:  J Dermatol Sci       Date:  2007-06-15       Impact factor: 4.563

Review 4.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

5.  An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis.

Authors:  Roland E Kälin; Nadja E Bänziger-Tobler; Michael Detmar; André W Brändli
Journal:  Blood       Date:  2009-05-28       Impact factor: 22.113

Review 6.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

7.  Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study.

Authors:  Subhra Mandal; Guobin Kang; Pavan Kumar Prathipati; Wenjin Fan; Qingsheng Li; Christopher J Destache
Journal:  Antiviral Res       Date:  2018-06-06       Impact factor: 5.970

8.  Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.

Authors:  Byung-Hak Kim; Junyeop Lee; Jun-Sub Choi; Dae Young Park; Ho Young Song; Tae Kyo Park; Chung-Hyun Cho; Sang-Kyu Ye; Choun-Ki Joo; Gou Young Koh; Tae-Yoon Kim
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

9.  HGF and MET mutations in primary and secondary lymphedema.

Authors:  David N Finegold; Vivien Schacht; Mark A Kimak; Elizabeth C Lawrence; Etelka Foeldi; Jenny M Karlsson; Catherine J Baty; Robert E Ferrell
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

10.  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.

Authors:  Tatsuma Okazaki; Amy Ni; Oluwasheyi A Ayeni; Peter Baluk; Li-Chin Yao; Doerte Vossmeyer; Gunther Zischinsky; Grit Zahn; Jochen Knolle; Claudia Christner; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.